PRIMARY STUDY

Biological bases for a possible effect of cannabidiol in Parkinson's disease

Key Findings:  6 pre-clinical trials showed neuro-protective effects after treatment with CBD; 3 found anti-dyskinetic induced by CBD; 3 human trials tested CBD in PD patients: an open-label study, a case series, and a randomized controlled trial—all reported therapeutic effects of CBD on non-motor symptoms.

Type of Study:  Meta-analysis

Study Result:  Positive


Cannabinoids Studied:  Cannabidiol (CBD)

Phytocannabinoid Source:  Not Applicable

Chemotype:  Chemotype III

Form of Administration:  Not Applicable


Study Location(s):  Brazil

Year of Pub:  2020


Link to study